Executive Summary In this white paper the authors explore how Bayesian dosing tools alleviate the cost and difficulty of implementing AUC24-based dosing in order to improve patient outcomes. This was achieved by comparing therapeutic range attainment amongst hospitals using trough-based...
Read more
We recently went live with DoseMeRx™ in Epic’s electronic health record (EHR). We’re frequently asked about the process to integrate DoseMeRx within the EHR, particularly as more health systems move towards Bayesian dosing optimization to comply with the forthcoming revised 2019 vancomycin...
Read more
In just under one month, DoseMe will be exhibiting at the 2019 ASHP Midyear Clinical Meeting in Las Vegas, NV from December 4th - 8th. Cerner PowerChart & Epic Hyperspace Integration This year, using SMART® on FHIR® technologies, we integrated...
Read more
The 2009 guidelines for monitoring vancomycin levels in adult patients recommended patients: Maintain trough serum vancomycin concentrations of at least 10 mg/L for all infections to avoid the potential for resistance Maintain trough serum vancomycin concentrations of 15-20mg/L for complicated infections The 2019...
Read moreHIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2019 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.
